4.3 Article

Medical treatment of acromegaly-experience from the Croatian acromegaly registry

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan

Marek Bolanowski et al.

Summary: Acromegaly is a rare condition caused by benign pituitary adenomas, and there are marked differences in its management among different countries. Improving coordination and participation in acromegaly registries are crucial for optimizing patient care.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Innovative therapeutics in acromegaly

Leandro Kasuki et al.

Summary: This review summarizes the recent innovations in the treatment of acromegaly and highlights the need for changes in the traditional trial and error approach as well as the development of new drugs to improve treatment outcomes.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Endocrinology & Metabolism

Medical Therapy of Acromegaly in Germany 2019-Data from the German Acromegaly Registry

Marcus Quinkler et al.

Summary: In German patients with acromegaly, most patients receiving medical therapy have normal or low IGF-1 levels. The majority of patients are treated with somatostatin analogs, with some patients using a combination of different medical regimens. Some patients did not achieve normalization of IGF-1 levels.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2021)

Article Clinical Neurology

Gamma-knife radiosurgery in acromegaly: the results from the Croatian acromegaly registry

Tanja Skoric Polovina et al.

Summary: The study evaluated the efficacy and safety of Leksell gamma-knife radiosurgery in residual growth hormone-secreting pituitary adenomas. It found that radiosurgery offers endocrine remission and tumor growth control in a substantial proportion of patients with GH-secreting adenomas.

BRITISH JOURNAL OF NEUROSURGERY (2021)

Article Endocrinology & Metabolism

Biochemical Control in Acromegaly With Multimodality Therapies: Outcomes From a Pituitary Center and Changes Over Time

Alireza Ghajar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

MEDICAL TREATMENT LANDSCAPE FOR ACTIVE ACROMEGALY IN A PITUITARY CENTER IN ISRAEL

Hiba Masri-Iraqi et al.

ENDOCRINE PRACTICE (2020)

Review Endocrinology & Metabolism

Pituitary Tumors Centers of Excellence

Stefano Frara et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)

Review Endocrinology & Metabolism

Multidisciplinary management of acromegaly: A consensus

Andrea Giustina et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)

Review Endocrinology & Metabolism

National acromegaly registries

Luigi Maione et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Endocrinology & Metabolism

Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant

Christian J. Strasburger et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Hypopituitarism after gamma knife radiosurgery for pituitary adenoma

Karin Zibar Tomsic et al.

ENDOCRINE RESEARCH (2017)

Article Endocrinology & Metabolism

Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly

S. J. C. M. M. Neggers et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Article Endocrinology & Metabolism

Acromegaly: An Endocrine Society Clinical Practice Guideline

Laurence Katznelson et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Endocrinology & Metabolism

Resistance to Somatostatin Analogs in Acromegaly

Annamaria Colao et al.

ENDOCRINE REVIEWS (2011)

Article Endocrinology & Metabolism

Outcome of gamma knife radiosurgery in 82 patients with acromegaly:: Correlation with initial hypersecretion

F Castinetti et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Endocrinology & Metabolism

Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly

JJ Puder et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)